NCT01764945View on ClinicalTrials.gov

Relative Bioavailability of BI 201335 Capsule Versus Three Different Oral Solutions

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Healthy
Interventions
DRUG

BI 201335 (Reference)

soft gelatine capsule, oral administration

DRUG

BI 201335 (Test)

oral solution 3

DRUG

BI 201335 (Test)

oral solution 3

DRUG

BI 201335 (Test)

oral solution 2

DRUG

BI 201335 (Reference)

soft gelatine capsule, oral administration

DRUG

BI 201335 (Test)

oral solution 1

DRUG

BI 201335 (Test)

oral solution 1

DRUG

BI 201335 (Test)

oral solution 2

Trial Locations (1)

Unknown

1220.46.1 Boehringer Ingelheim Investigational Site, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY